DexCom Reports Q1 2026 Earnings with Strong Revenue Growth and Improved Margins
DexCom (DXCM) reported Q1 2026 earnings with worldwide revenue of $1.19 billion, reflecting 15% reported growth and 12% organic growth. The company saw improved gross profit margins and strong performance in both U.S. and international markets, driven by product launches and expanded coverage.

Tickers: $DXCM
Topics: Earnings Operating Expenses Profit Margins Revenue Growth Stock Performance